The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Genetic Disease Diagnosis Market Research Report 2024
Synopsis
The global Genetic Disease Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Genetic Disease Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Disease Diagnosis.
Report Scope
The Genetic Disease Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genetic Disease Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Disease Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Siemens Healthineers
Roche Diagnostics Corp
Bayer Diagnostics
Sysmex Corporation
Cephide
Bio-Rad Laboratories
Thermo Fisher Scientific
Illumina, Inc
Applied Biosystems
Transgenomic Inc
AutoGenomics
Segment by Type
Robotic Radiosurgery
Usage Of Molecular Target Agents
Others
Segment by Application
Inherited Disorder Testing
Pharmacogenetic Testing (PGx)
Human Leukocyte Antigen (HLA) Testing
Oncology Testing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetic Disease Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Genetic Disease Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Genetic Disease Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Disease Diagnosis.
Report Scope
The Genetic Disease Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genetic Disease Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Disease Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Siemens Healthineers
Roche Diagnostics Corp
Bayer Diagnostics
Sysmex Corporation
Cephide
Bio-Rad Laboratories
Thermo Fisher Scientific
Illumina, Inc
Applied Biosystems
Transgenomic Inc
AutoGenomics
Segment by Type
Robotic Radiosurgery
Usage Of Molecular Target Agents
Others
Segment by Application
Inherited Disorder Testing
Pharmacogenetic Testing (PGx)
Human Leukocyte Antigen (HLA) Testing
Oncology Testing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetic Disease Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Disease Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Robotic Radiosurgery
1.2.3 Usage Of Molecular Target Agents
1.2.4 Others
1.3 Market by Application
1.3.1 Global Genetic Disease Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Inherited Disorder Testing
1.3.3 Pharmacogenetic Testing (PGx)
1.3.4 Human Leukocyte Antigen (HLA) Testing
1.3.5 Oncology Testing
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genetic Disease Diagnosis Market Perspective (2019-2030)
2.2 Genetic Disease Diagnosis Growth Trends by Region
2.2.1 Global Genetic Disease Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Genetic Disease Diagnosis Historic Market Size by Region (2019-2024)
2.2.3 Genetic Disease Diagnosis Forecasted Market Size by Region (2025-2030)
2.3 Genetic Disease Diagnosis Market Dynamics
2.3.1 Genetic Disease Diagnosis Industry Trends
2.3.2 Genetic Disease Diagnosis Market Drivers
2.3.3 Genetic Disease Diagnosis Market Challenges
2.3.4 Genetic Disease Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genetic Disease Diagnosis Players by Revenue
3.1.1 Global Top Genetic Disease Diagnosis Players by Revenue (2019-2024)
3.1.2 Global Genetic Disease Diagnosis Revenue Market Share by Players (2019-2024)
3.2 Global Genetic Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genetic Disease Diagnosis Revenue
3.4 Global Genetic Disease Diagnosis Market Concentration Ratio
3.4.1 Global Genetic Disease Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Disease Diagnosis Revenue in 2023
3.5 Genetic Disease Diagnosis Key Players Head office and Area Served
3.6 Key Players Genetic Disease Diagnosis Product Solution and Service
3.7 Date of Enter into Genetic Disease Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genetic Disease Diagnosis Breakdown Data by Type
4.1 Global Genetic Disease Diagnosis Historic Market Size by Type (2019-2024)
4.2 Global Genetic Disease Diagnosis Forecasted Market Size by Type (2025-2030)
5 Genetic Disease Diagnosis Breakdown Data by Application
5.1 Global Genetic Disease Diagnosis Historic Market Size by Application (2019-2024)
5.2 Global Genetic Disease Diagnosis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Genetic Disease Diagnosis Market Size (2019-2030)
6.2 North America Genetic Disease Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Genetic Disease Diagnosis Market Size by Country (2019-2024)
6.4 North America Genetic Disease Diagnosis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genetic Disease Diagnosis Market Size (2019-2030)
7.2 Europe Genetic Disease Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Genetic Disease Diagnosis Market Size by Country (2019-2024)
7.4 Europe Genetic Disease Diagnosis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genetic Disease Diagnosis Market Size (2019-2030)
8.2 Asia-Pacific Genetic Disease Diagnosis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Genetic Disease Diagnosis Market Size by Region (2019-2024)
8.4 Asia-Pacific Genetic Disease Diagnosis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genetic Disease Diagnosis Market Size (2019-2030)
9.2 Latin America Genetic Disease Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Genetic Disease Diagnosis Market Size by Country (2019-2024)
9.4 Latin America Genetic Disease Diagnosis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genetic Disease Diagnosis Market Size (2019-2030)
10.2 Middle East & Africa Genetic Disease Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Genetic Disease Diagnosis Market Size by Country (2019-2024)
10.4 Middle East & Africa Genetic Disease Diagnosis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Genetic Disease Diagnosis Introduction
11.1.4 Abbott Laboratories Revenue in Genetic Disease Diagnosis Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Siemens Healthineers
11.2.1 Siemens Healthineers Company Detail
11.2.2 Siemens Healthineers Business Overview
11.2.3 Siemens Healthineers Genetic Disease Diagnosis Introduction
11.2.4 Siemens Healthineers Revenue in Genetic Disease Diagnosis Business (2019-2024)
11.2.5 Siemens Healthineers Recent Development
11.3 Roche Diagnostics Corp
11.3.1 Roche Diagnostics Corp Company Detail
11.3.2 Roche Diagnostics Corp Business Overview
11.3.3 Roche Diagnostics Corp Genetic Disease Diagnosis Introduction
11.3.4 Roche Diagnostics Corp Revenue in Genetic Disease Diagnosis Business (2019-2024)
11.3.5 Roche Diagnostics Corp Recent Development
11.4 Bayer Diagnostics
11.4.1 Bayer Diagnostics Company Detail
11.4.2 Bayer Diagnostics Business Overview
11.4.3 Bayer Diagnostics Genetic Disease Diagnosis Introduction
11.4.4 Bayer Diagnostics Revenue in Genetic Disease Diagnosis Business (2019-2024)
11.4.5 Bayer Diagnostics Recent Development
11.5 Sysmex Corporation
11.5.1 Sysmex Corporation Company Detail
11.5.2 Sysmex Corporation Business Overview
11.5.3 Sysmex Corporation Genetic Disease Diagnosis Introduction
11.5.4 Sysmex Corporation Revenue in Genetic Disease Diagnosis Business (2019-2024)
11.5.5 Sysmex Corporation Recent Development
11.6 Cephide
11.6.1 Cephide Company Detail
11.6.2 Cephide Business Overview
11.6.3 Cephide Genetic Disease Diagnosis Introduction
11.6.4 Cephide Revenue in Genetic Disease Diagnosis Business (2019-2024)
11.6.5 Cephide Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Genetic Disease Diagnosis Introduction
11.7.4 Bio-Rad Laboratories Revenue in Genetic Disease Diagnosis Business (2019-2024)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Genetic Disease Diagnosis Introduction
11.8.4 Thermo Fisher Scientific Revenue in Genetic Disease Diagnosis Business (2019-2024)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Illumina, Inc
11.9.1 Illumina, Inc Company Detail
11.9.2 Illumina, Inc Business Overview
11.9.3 Illumina, Inc Genetic Disease Diagnosis Introduction
11.9.4 Illumina, Inc Revenue in Genetic Disease Diagnosis Business (2019-2024)
11.9.5 Illumina, Inc Recent Development
11.10 Applied Biosystems
11.10.1 Applied Biosystems Company Detail
11.10.2 Applied Biosystems Business Overview
11.10.3 Applied Biosystems Genetic Disease Diagnosis Introduction
11.10.4 Applied Biosystems Revenue in Genetic Disease Diagnosis Business (2019-2024)
11.10.5 Applied Biosystems Recent Development
11.11 Transgenomic Inc
11.11.1 Transgenomic Inc Company Detail
11.11.2 Transgenomic Inc Business Overview
11.11.3 Transgenomic Inc Genetic Disease Diagnosis Introduction
11.11.4 Transgenomic Inc Revenue in Genetic Disease Diagnosis Business (2019-2024)
11.11.5 Transgenomic Inc Recent Development
11.12 AutoGenomics
11.12.1 AutoGenomics Company Detail
11.12.2 AutoGenomics Business Overview
11.12.3 AutoGenomics Genetic Disease Diagnosis Introduction
11.12.4 AutoGenomics Revenue in Genetic Disease Diagnosis Business (2019-2024)
11.12.5 AutoGenomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Genetic Disease Diagnosis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Robotic Radiosurgery
Table 3. Key Players of Usage Of Molecular Target Agents
Table 4. Key Players of Others
Table 5. Global Genetic Disease Diagnosis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Genetic Disease Diagnosis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Genetic Disease Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Genetic Disease Diagnosis Market Share by Region (2019-2024)
Table 9. Global Genetic Disease Diagnosis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Genetic Disease Diagnosis Market Share by Region (2025-2030)
Table 11. Genetic Disease Diagnosis Market Trends
Table 12. Genetic Disease Diagnosis Market Drivers
Table 13. Genetic Disease Diagnosis Market Challenges
Table 14. Genetic Disease Diagnosis Market Restraints
Table 15. Global Genetic Disease Diagnosis Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Genetic Disease Diagnosis Market Share by Players (2019-2024)
Table 17. Global Top Genetic Disease Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Disease Diagnosis as of 2023)
Table 18. Ranking of Global Top Genetic Disease Diagnosis Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Genetic Disease Diagnosis Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Genetic Disease Diagnosis Product Solution and Service
Table 22. Date of Enter into Genetic Disease Diagnosis Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genetic Disease Diagnosis Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Genetic Disease Diagnosis Revenue Market Share by Type (2019-2024)
Table 26. Global Genetic Disease Diagnosis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Genetic Disease Diagnosis Revenue Market Share by Type (2025-2030)
Table 28. Global Genetic Disease Diagnosis Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Genetic Disease Diagnosis Revenue Market Share by Application (2019-2024)
Table 30. Global Genetic Disease Diagnosis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Genetic Disease Diagnosis Revenue Market Share by Application (2025-2030)
Table 32. North America Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Genetic Disease Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Genetic Disease Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Genetic Disease Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Genetic Disease Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Genetic Disease Diagnosis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Genetic Disease Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Genetic Disease Diagnosis Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Genetic Disease Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Genetic Disease Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Genetic Disease Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Genetic Disease Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abbott Laboratories Company Detail
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Genetic Disease Diagnosis Product
Table 50. Abbott Laboratories Revenue in Genetic Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. Siemens Healthineers Company Detail
Table 53. Siemens Healthineers Business Overview
Table 54. Siemens Healthineers Genetic Disease Diagnosis Product
Table 55. Siemens Healthineers Revenue in Genetic Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 56. Siemens Healthineers Recent Development
Table 57. Roche Diagnostics Corp Company Detail
Table 58. Roche Diagnostics Corp Business Overview
Table 59. Roche Diagnostics Corp Genetic Disease Diagnosis Product
Table 60. Roche Diagnostics Corp Revenue in Genetic Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 61. Roche Diagnostics Corp Recent Development
Table 62. Bayer Diagnostics Company Detail
Table 63. Bayer Diagnostics Business Overview
Table 64. Bayer Diagnostics Genetic Disease Diagnosis Product
Table 65. Bayer Diagnostics Revenue in Genetic Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 66. Bayer Diagnostics Recent Development
Table 67. Sysmex Corporation Company Detail
Table 68. Sysmex Corporation Business Overview
Table 69. Sysmex Corporation Genetic Disease Diagnosis Product
Table 70. Sysmex Corporation Revenue in Genetic Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 71. Sysmex Corporation Recent Development
Table 72. Cephide Company Detail
Table 73. Cephide Business Overview
Table 74. Cephide Genetic Disease Diagnosis Product
Table 75. Cephide Revenue in Genetic Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 76. Cephide Recent Development
Table 77. Bio-Rad Laboratories Company Detail
Table 78. Bio-Rad Laboratories Business Overview
Table 79. Bio-Rad Laboratories Genetic Disease Diagnosis Product
Table 80. Bio-Rad Laboratories Revenue in Genetic Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 81. Bio-Rad Laboratories Recent Development
Table 82. Thermo Fisher Scientific Company Detail
Table 83. Thermo Fisher Scientific Business Overview
Table 84. Thermo Fisher Scientific Genetic Disease Diagnosis Product
Table 85. Thermo Fisher Scientific Revenue in Genetic Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 86. Thermo Fisher Scientific Recent Development
Table 87. Illumina, Inc Company Detail
Table 88. Illumina, Inc Business Overview
Table 89. Illumina, Inc Genetic Disease Diagnosis Product
Table 90. Illumina, Inc Revenue in Genetic Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 91. Illumina, Inc Recent Development
Table 92. Applied Biosystems Company Detail
Table 93. Applied Biosystems Business Overview
Table 94. Applied Biosystems Genetic Disease Diagnosis Product
Table 95. Applied Biosystems Revenue in Genetic Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 96. Applied Biosystems Recent Development
Table 97. Transgenomic Inc Company Detail
Table 98. Transgenomic Inc Business Overview
Table 99. Transgenomic Inc Genetic Disease Diagnosis Product
Table 100. Transgenomic Inc Revenue in Genetic Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 101. Transgenomic Inc Recent Development
Table 102. AutoGenomics Company Detail
Table 103. AutoGenomics Business Overview
Table 104. AutoGenomics Genetic Disease Diagnosis Product
Table 105. AutoGenomics Revenue in Genetic Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 106. AutoGenomics Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genetic Disease Diagnosis Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Genetic Disease Diagnosis Market Share by Type: 2023 VS 2030
Figure 3. Robotic Radiosurgery Features
Figure 4. Usage Of Molecular Target Agents Features
Figure 5. Others Features
Figure 6. Global Genetic Disease Diagnosis Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Genetic Disease Diagnosis Market Share by Application: 2023 VS 2030
Figure 8. Inherited Disorder Testing Case Studies
Figure 9. Pharmacogenetic Testing (PGx) Case Studies
Figure 10. Human Leukocyte Antigen (HLA) Testing Case Studies
Figure 11. Oncology Testing Case Studies
Figure 12. Others Case Studies
Figure 13. Genetic Disease Diagnosis Report Years Considered
Figure 14. Global Genetic Disease Diagnosis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Genetic Disease Diagnosis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Genetic Disease Diagnosis Market Share by Region: 2023 VS 2030
Figure 17. Global Genetic Disease Diagnosis Market Share by Players in 2023
Figure 18. Global Top Genetic Disease Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Disease Diagnosis as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Genetic Disease Diagnosis Revenue in 2023
Figure 20. North America Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Genetic Disease Diagnosis Market Share by Country (2019-2030)
Figure 22. United States Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Genetic Disease Diagnosis Market Share by Country (2019-2030)
Figure 26. Germany Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Genetic Disease Diagnosis Market Share by Region (2019-2030)
Figure 34. China Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Genetic Disease Diagnosis Market Share by Country (2019-2030)
Figure 42. Mexico Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Genetic Disease Diagnosis Market Share by Country (2019-2030)
Figure 46. Turkey Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Genetic Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Abbott Laboratories Revenue Growth Rate in Genetic Disease Diagnosis Business (2019-2024)
Figure 49. Siemens Healthineers Revenue Growth Rate in Genetic Disease Diagnosis Business (2019-2024)
Figure 50. Roche Diagnostics Corp Revenue Growth Rate in Genetic Disease Diagnosis Business (2019-2024)
Figure 51. Bayer Diagnostics Revenue Growth Rate in Genetic Disease Diagnosis Business (2019-2024)
Figure 52. Sysmex Corporation Revenue Growth Rate in Genetic Disease Diagnosis Business (2019-2024)
Figure 53. Cephide Revenue Growth Rate in Genetic Disease Diagnosis Business (2019-2024)
Figure 54. Bio-Rad Laboratories Revenue Growth Rate in Genetic Disease Diagnosis Business (2019-2024)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Genetic Disease Diagnosis Business (2019-2024)
Figure 56. Illumina, Inc Revenue Growth Rate in Genetic Disease Diagnosis Business (2019-2024)
Figure 57. Applied Biosystems Revenue Growth Rate in Genetic Disease Diagnosis Business (2019-2024)
Figure 58. Transgenomic Inc Revenue Growth Rate in Genetic Disease Diagnosis Business (2019-2024)
Figure 59. AutoGenomics Revenue Growth Rate in Genetic Disease Diagnosis Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
